NCT03305666View on ClinicalTrials.gov

Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 5, 2017

Primary Completion Date

July 20, 2020

Study Completion Date

January 31, 2021

Conditions
Drug EffectRib FracturesRib TraumaSurgical Procedure, UnspecifiedPain; Catheter (Other)Nerve PainLocal InfiltrationAnesthesia, LocalIntercostal RibOpioid DependenceChest Injury TraumaPneumonia
Interventions
DRUG

Liposomal bupivacaine injection

A single injection of liposomal bupivacaine is administered at the time of SSRF, directly to the fracture site via VATS

DRUG

Bupivacaine indwelling catheter

Bupivacaine indwelling OnQ pain pump catheter is placed in the subscapular space at the time of SSRF for continuous bupivacaine infusion post op

Trial Locations (1)

80204

Denver Health, Denver

All Listed Sponsors
lead

Denver Health and Hospital Authority

OTHER

NCT03305666 - Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures | Biotech Hunter | Biotech Hunter